CASI Pharmaceuticals, Inc. raised $15 million in a private placement financing led by Venrock Healthcare Capital Partners and Foresite Capital
Amount Raised
$15 Million
Round Type
Post-IPO Equity
RockvilleManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
CASI Pharmaceuticals, Inc. announced a private investment in public equity financing (PIPE Transaction) that is expected to result in aggregate gross proceeds of approximately $15.0 million. The financing is being led by Venrock Healthcare Capital Partners and Foresite Capital, with participation by Panacea Venture and Dr. Wei-Wu He.
Quick answer
CASI Pharmaceuticals raised $15 Million in a Post-IPO Equity round, dated June 26, 2024. Investors: Dr. Wei Wu He, Panacea Venture, Foresite Capital and Venrock Healthcare Capital Partners. CASI Pharmaceuticals is based in Rockville, Maryland, United States.
- How much did CASI Pharmaceuticals raise?
- CASI Pharmaceuticals raised $15 Million in a Post-IPO Equity round on June 26, 2024.
- Who invested in CASI Pharmaceuticals?
- Dr. Wei Wu He, Panacea Venture, Foresite Capital and Venrock Healthcare Capital Partners are named as investors in this round.
- What does CASI Pharmaceuticals do?
- CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.
- Where is CASI Pharmaceuticals based and how big is it?
- CASI Pharmaceuticals is based in Rockville, Maryland, United States. Fundz records about 45 employees.
- Who are the decision-makers at CASI Pharmaceuticals?
- Fundz holds 1 contact at CASI Pharmaceuticals, including the Senior Vice President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as CASI Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Ensho Therapeutics raised $400K on July 19, 2024.
- Renalys Pharma raised $38M (Series A) on July 17, 2024.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- IDRx raised $120M (Series B) on August 7, 2024.
- PolyPid raised $14M on August 6, 2024.
Who to call at CASI Pharmaceuticals, and when
A new round usually means CASI Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CASI Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CASI Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CASI Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CASI Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CASI Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.